We assessed the effectiveness of the 3-in-1 continuous femoral block as a form of postoperative pain relief for unilateral total knee arthroplasty (TKA). Sixty patients undergoing elective unilateral TKA under subarachnoid block were randomized into three groups. Postoperative analgesia was provided with a continuous 3-in-1 femoral nerve catheter with 0.15% ropivacaine in group A, a continuous 3-in-1 femoral nerve catheter with 0.2% ropivacaine in group B, or patient controlled intravenous morphine in group C (control group). Groups A and B received patient controlled intravenous morphine pumps for rescue analgesia. Patients in each group were followed for 72 hours postoperatively. Five patients were excluded after randomization. In the remaining 55 patients there was no statistical difference in pain score between the groups. Total morphine use was highest in group C (P< 0.05). No appreciable difference could be found with sensorimotor blockade, morphine usage and satisfaction scores when comparing groups A and B. Femoral catheter dislodgement rate was 7.9%. There was no statistical difference between the groups when comparing the day of first ambulation and the time to discharge from the hospital. Satisfaction scores were higher in group A (P = 0.028) and group B (P = 0.002) compared to group C. We conclude that a continuous 3-in-1 femoral nerve block with ropivacaine 0.15% or 0.2% for elective unilateral TKA has an opioid-sparing effect.
Postoperative pain after total knee arthroplasty (TKA) is of major concern. It is severe in 60% of patients and moderate in 30% 1 . It also hinders postoperative mobilization (continuous passive motion) and physiotherapy, which is the most influential factor in good postoperative rehabilitation 2 . Achieving adequate analgesia is still a true clinical challenge.
After TKA, postoperative pain relief can be achieved by a variety of techniques, such as patient controlled analgesia (PCA) with intravenous opioids 3 , epidural analgesia with local anaesthetics and/or opioids 4, 5 , intrathecal opioids 6 , and the single injection or 3-in-1 continuous femoral block (first described by Winnie et al in 1973) 6, 7, 8 . Combination peripheral nerve blocks (sciatic, obturator and femoral) have also been performed 9, 10 . It is suggested that loco-regional analgesic techniques (lumbar epidural blocks and 3-in-1 blocks) provide better pain relief than intravenous morphine 11 .
The knee is innervated by the lumbosacral plexus. The femoral and obturator nerves innervate the anterior aspect of the knee and the sciatic nerve innervates the posterior aspect. The 3-in-1 continuous femoral block involves the injection of local anaesthetic into the perineural sheath surrounding the femoral nerve to obtain blockade of the femoral nerve, obturator nerve and the lateral cutaneous nerve of the thigh. Theoretically, the sciatic, obturator and femoral nerves have to be blocked for analgesia after knee surgery. opinion is divided as to whether the sole blockade of the femoral nerve is sufficient for post TKA analgesia. on one hand, it has been found that a combination of the sciatic and femoral nerve block does not provide additional benefit for postoperative analgesia as compared to femoral nerve block 12 . on the other hand, it has been shown that adequate analgesia after TKA cannot be achieved with a continuous femoral block alone and the addition of a continuous sciatic block renders significant improvement in analgesia 9 . In another study, addition of an obturator nerve block to the femoral nerve block improves postoperative analgesia after TKA 10 . ng et al showed that a lower ropivacaine concentration of 0.25% has similar efficacy compared to 0.5% ropivacaine and 0.25% bupivacaine for a single shot 3-in-1 femoral nerve block 13 .
In our institution, the mainstay of analgesia postoperatively after TKA is PCA with intravenous morphine. We assessed the efficacy of the 3-in-1 continuous femoral block compared to PCA with intravenous morphine for the purpose of post TKA analgesia and rehabilitation. We also ascertained if differences exist using two different concentrations (0.15% and 0.2%) of ropivacaine for the 3-in-1 continuous femoral nerve block in a prospective randomized controlled trial.
MATERIALS AnD METhoDS
After institutional approval and informed consent, 60 patients undergoing TKA in Singapore general hospital were selected according to the following inclusion and exclusion criteria. The inclusion criteria for the study were ASA I, II and III patients scheduled for elective unilateral TKA for osteoarthritis of the knee under lumbar subarachnoid block. We excluded patients with contraindication to a lumbar subarachnoid block (e.g. coagulopathy, local infection, sepsis, previous lumbar spine operation), patients who preferred general anaesthesia, patients less than 40 kg or greater than 120 kg, patients with allergies to the drugs to be used, patients with rheumatoid arthritis, and patients with preexisting lower limb neurological deficits.
The 60 patients were randomized into three groups (20 patients in each group). Each of the three groups received postoperative analgesia according to a preassigned method: A. Ropivacaine 0.15% via the 3-in-1 continuous femoral block at 10 ml/hr during the first 24 hours and then at 5 ml/h during the next 24 hours with supplementary intravenous PCA morphine (concentration 1 mg/ml, on-demand bolus doses of 1 mg with a lockout period of 5 minutes and a maximum dosage of 8 mg/h). B. Ropivacaine 0.2% via the 3-in-1 continuous femoral block at 10 ml/hr during the first 24 hours and then at 5 ml/h during the next 24 hours with supplementary intravenous PCA morphine (concentration 1 mg/ml, on-demand bolus doses of 1 mg with a lockout period of 5 minutes and a maximum dosage of 8 mg/h). C. Intravenous PCA with morphine alone (concentration 1 mg/ml, on-demand bolus doses of 1 mg with a lockout period of 5 minutes and a maximum dosage of 8 mg/h). In all groups, 50 mg of oral rofecoxib was first given 30 minutes before the start of the operation. In groups A and B, the continuous femoral 3-in-1 blocks were performed in the induction room before the administration of the lumbar subarachnoid block. The blocks were performed by one author (ASnY), who was not involved in the postoperative followup and data collection. The femoral artery was first palpated below the inguinal ligament and the femoral nerve was then located about 0.5 cm lateral to it using a peripheral nerve stimulator attached to a Contiplex 18-gauge Tuohy needle. Motor response involving the ascension of the patella was obtained at less than 0.3 mA. A 20-gauge catheter was then threaded 10-15 cm into the psoas compartment. After a negative aspiration test for blood and cerebrospinal fluid 14 , the catheter was secured to the skin. A test dose of 0.25% bupivacaine 10 ml was then given via the 3-in-1 femoral catheter. groups A and B also received a PCA pump with intravenous morphine (as detailed above) for rescue therapy in the event that the 3-in-1 continuous femoral nerve block was inadequate as a sole means of analgesia. This would also allow easy comparison between the groups on the total morphine usage.
In all the groups, just before the commencement of surgery, a lumbar subarachnoid block was performed at the L4/5 or L3/4 position and hyperbaric 0.5% bupivacaine 2.0 to 3.0 ml was administered intrathecally. Intraoperative sedation (midazolam or propofol titrated to effect) was given. Intravenous Ringer's lactate was administered to replace fluid volume according to the period of fasting and subsequently maintained at 2 to 5 ml/kg/h. Vasoconstrictors were given intravenously at the discretion of the attending anaesthetist if the mean arterial pressure fell below 15% of the patient's individual baseline blood pressure. no wound infiltration of local anaesthetic and no prophylactic antiemetics were given.
The 3-in-1 continuous femoral block infusion of local anaesthetic was started for postoperative analgesia at the conclusion of the surgery in groups A and B. In all groups, the PCA pump was connected and started in the post anaesthesia care unit, delivering 1 mg boluses of morphine on-demand with a 5-minute lockout period and a maximum dose of 8 mg per hour. Postoperatively in the general orthopaedic ward, oral paracetamol 1000 mg six hourly and oral rofecoxib 50 mg each morning were given for supplemental analgesia. If nausea and vomiting developed in the postoperative period, intravenous ondansetron 4 mg was given up to 8 hourly.
Several outcome parameters were assessed postoperatively at 6 hours, 12 hours, 24 hours, 48 hours and 72 hours to compare the efficacy of the various analgesic regimens. These included: 1. Visual analogue score (VAS) for pain at rest and on movement (0=no pain, 10=worst possible pain). 2. Total cumulative morphine used (in mg). 3. Sensory blockade (femoral and obturator distribution, tested with loss of sensation to cold over the anterior thigh and medial aspect of the knee). 4. Motor blockade using the Bromage scale (1=free movement of legs/feet, 2=able to flex knee with free movement of feet, 3=unable to flex knees but with free movement of feet, 4=unable to move legs/feet). 5. Side-effects of intravenous morphine (urinary retention after catheter removal, pruritus, sedation [score 0=awake; 1=sleepy but awakened by oral order; 2=sleepy but awakened by nociceptive stimulation; 3=not awakened], hypotension of <15% baseline, and giddiness). 6. Time to ambulation (in hours). 7. Patient satisfaction score (0=very dissatisfied, 10=very satisfied). 8. Time to discharge from hospital (in days). 9. Femoral catheter complication (e.g. occlusion, kinks, haematoma, displacement, inflammation, subcutaneous swelling, neurologic deficit). Immediately after surgery, all three groups were started on similar physiotherapy regimens. During the first 24 hours postoperatively, a continuous passive motion machine was applied, with the range of motion set at levels tolerated well by the patient. Ambulation with a walker was encouraged as soon as possible.
Sample size calculation indicated that 14 subjects per group would allow us to detect a difference of 10 mg total cumulative morphine use (with SD=9 from previous pilot study) between the control group and any of the two arms with ropivacaine at power =0.8, and a=0.05. The Mann-Whitney and Kruskal Wallis tests were used to compare ordinal data such as satisfaction scores between two and three groups respectively. Continuous data such as total cumulative morphine usage measured at various time points (6, 12, 24, 48 and 72 hours postoperatively) was analysed using AnoVA with repeated measures. Chi-square test was used to analyse dichotomous data such as incidence of nausea and vomiting. A P value of <0.05 was considered statistically significant.
RESULTS
of the 60 patients that were randomized, five patients were excluded after randomization (one patient unable to locate subarachnoid space and given a general anaesthetic, one patient with inadequate subarachnoid block with conversion to general anaesthesia midway through the operation, and three slipped femoral catheters postoperatively). Including the results from these five patients would influence the overall effect of the 3-in-1 block and therefore these patients were excluded from analysis. Population data of the 55 patients (age, weight and gender ratio) were comparable in all the three groups (Table 1) . Mean±SD.
The average VAS for pain (at rest and on movement) at the various times of assessment is reflected as a graph in Figure 1a and 1b. The pain scores were analysed with AnoVA with repeated measures, analysing the six time points (preoperatively, 6 hours, 12 hours, 24 hours, 48 hours and 72 hours postoperatively) between comparison groups. The overall VAS over time for both at rest and on movement was not significantly different between the three groups (P=0.274 and P=0.826 respectively).
The average total consumption of intravenous morphine in group C was the highest (Figure 2 ). AnoVA with repeated measures with Tukey post-hoc test showed that throughout the postoperative period group C has significantly higher morphine usage than groups A and B (P<0.0005 and P=0.023 respectively). There was no difference between group A compared to group B. Table 2 tabulates the number of patients in each group with opioid-related side effects and amount of intravenous ondansetron usage (in mg) in the three groups. There were no significant differences in postoperative nausea and vomiting (PonV), ondansetron use, or sedation when group C was compared to groups A and B (P>0.05). however, the study may have been inadequately powered for these outcome measures.
The percentage of patients with sensory block of the femoral and the obturator distributions at the E. SEEt, W. L. LEong Et aL various postoperative times are similar in group A and group B at all times when this was analysed using Fisher's exact test. This suggests that 0.15% ropivacaine has a similar effect in blocking the sensory nerves compared to 0.2% ropivacaine. Comparing the trend and degree of motor block (Bromage score) at the various postoperative time intervals using the chi-square test for trend, there was also no significant difference between groups A and B. however, no power analyses were performed for these comparisons.
none of the patients in the two groups using local anaesthetics showed symptoms or signs of local anaesthetic toxicity. Three femoral catheters were dislodged before the conclusion of the 72-hour period. Two of them were dislodged in the first 24 hours and these were excluded from analysis. There were no documented complications related to the femoral catheters such as femoral site infection, haematomas, subcutaneous swellings or neurologic deficits.
The median day of first ambulation and interquartile range (25th to 75th percentile) and the duration of hospital stay are shown in Table 3 . Using Kruskal Wallis test, there was no significant difference between the three groups. Patient satisfaction scores are shown in Figure 3 . Using Mann-Whitney test to compare within the various groups, group A has higher satisfaction scores compared to group C (P value=0.028) and group B has a higher satisfaction score compared to group C (P value=0.002).
DISCUSSIon
We found that the continuous 3-in-1 femoral nerve block has an opioid-sparing effect and it is associated with more favourable patient satisfaction scores, although it is not associated with better pain scores. A concentration of ropivacaine 0.15% appeared equally effective as 0.2% ropivacaine.
Poorly controlled pain in the postoperative period can cause serious complications, such as pulmonary or urinary problems, thromboembolism, hyperdynamic circulation and increased oxygen consumption, and may also impair the ultimate functional outcome 15 . nnT = number needed to treat Systemic opioids are a popular postoperative analgesic regimen, but these are associated with sideeffects of nausea, vomiting, pruritus and sedation. Loco-regional techniques provide superior pain relief compared to conventional parenteral opioids 11, 16, 17 . Epidural analgesia is associated with the risk of neuraxial haematomas, unwanted hypotension and bilateral lower limb motor block. Therefore continuous 3-in-1 femoral nerve blocks may be considered more desirable post TKA 11, 18 . There have been conflicting views as to whether a femoral nerve block alone will provide adequate analgesia post TKA, as opposed to combined femoral and sciatic or combined femoral and obturator blocks 9,10,12 . Capdevilla et al and Allen et al concluded that a femoral block alone was sufficient 2, 12 . Bruce Ben-David et al and Macalou et al concluded that a continuous sciatic nerve block or an obturator nerve block was needed to improve analgesia with the 3-in-1 block after TKA 9, 10 . We chose to perform a 3-in-1 block alone for post TKA analgesia and have found there to be a significant opioid-sparing effect, which is a surrogate marker to analgesic success. Pain scores were not significantly different between the groups (AnoVA with repeated measures P=0.274 for VAS at rest, and P=0.824 for VAS on movement) unlike findings by Singelyn et al 11 . This is perhaps due to the fact that pre-emptive analgesia (preoperatively administered rofecoxib) and multimodal analgesia techniques (postoperative paracetamol and rofecoxib) were used. other contributing factors would be the feedback mechanism that patient-controlled intravenous morphine affords to the patient.
A previous study has demonstrated that the plasma concentration of continuous use of 0.2% bupivacaine for a 3-in-1 femoral nerve block was below the toxic range 19 . however venous plasma levels of bupivacaine (which is highly protein bound and with a large volume of distribution of 120 litres) may not reflect FEmoraL BLock vS Pca morPhinE For PoSt totaL knEE arthroPLaSty anaLgESia what is bound to excitable tissues in the heart and the brain. Anker-Moller et al have shown that 0.125% bupivacaine at a rate of 0.14 ml/kg/h gave the same analgesic effect as 0.25% bupivacaine when used to maintain the continuous 3-in-1 block 20 . ng et al has demonstrated that a lower concentration of 0.25% ropivacaine has similar efficacy compared to 0.5% ropivacaine and 0.25% bupivacaine for a single-shot femoral nerve block post TKA 13 .
Comparing group A (ropivacaine 0.15%) and group B (ropivacaine 0.2%), we found no appreciable difference in motor (chi-square test for trend) or sensory (Fisher's exact test) block at all the time points postoperatively with the 3-in-1 continuous femoral catheter. The pain scores and satisfaction scores in these two groups were also comparable. This may indicate that a lower concentration of 0.15% ropivacaine is sufficient for the femoral nerve block. There is a potential concern that that a continuous infusion of a large volume of local anaesthetic may lead to an increased risk of local anaesthetic toxicity (dizziness, tinnitus, visual disturbance, perioral numbness and seizures). Thus a dose-sparing concentration of 0.15% may be more desirable.
From a pilot study, it was found that pain scores decreased significantly 24 hours postoperatively. The rate of morphine use was also found to be lower after 24 hours. We therefore decided in our protocol to alter the rate of ropivacaine infusion from 10 ml/h in the first 24 hours to 5 ml/h thereafter. In this study, we found that the peak in the pain scores indeed corresponded to the 6 and 12 hour postoperative periods ( Figure 2 ).
Catheter-related problems were the main source of failure in the patients receiving a continuous peripheral nerve block. We found that there were three (7.9%) femoral catheters dislodged during the course of the study. Two of the three catheters were dislodged on the first day of review during transfer from the operating theatre to the general orthopaedic ward. The last patient had the catheter dislodged on the last day of review. none of the patients with femoral catheters had other significant catheterrelated complications of haematomas, inflammation, subcutaneous swelling and neurological deficits.
We chose a functional assessment of the rehabilitation as the day of first walk and duration of hospital stay until discharge (Table 3) . From our study, there was no statistical difference between the groups. This is in contrast to the findings by Singelyn et al 11 . our study was not adequately powered to detect differences in ambulation and discharge times.
Patient satisfaction scores in the two groups receiving continuous peripheral nerve blocks via a 3-in-1 femoral catheter reported more favourably ( Figure  3 ) although the pain scores were not statistically different. Achieving a technique of analgesia with more satisfied patients is advantageous in a culture of increasingly customer-centric practice of medicine.
In conclusion, our study has demonstrated an opioid-sparing effect with the continuous 3-in-1 femoral nerve blocks. Patients in these groups also report higher satisfaction scores. There was no significant difference between the use of 0.2% and 0.15% ropivacaine, suggesting the lower concentration may be adequate.
